Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Molecular Oncology Diagnostics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Instruments, Kits and Assays, Software)
5.2.2. By Technology (Fluorescence In-Situ Hybridization (FISH), Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Flow Cytometry, and Other Technologies)
5.2.3. By Application (Research, Clinical)
5.2.4. By Cancer Type {Solid Tumor (Breast Cancer, Ovarian Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, and Other Solid Tumors), Blood cancers (Lymphoma, Leukemia, Multiple Myeloma, and other Hematological Malignancies)}
5.2.5. By End User (Hospitals and Diagnostic Centers, Reference Laboratories, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes)
5.2.6. By Region (North America, Europe, Asia Pacific, South America, Middle East, and Africa)
5.2.7. By Company (2022)
5.3. Market Map
5.3.1. By Product Type
5.3.2. By Technology
5.3.3. By Application
5.3.4. By Cancer Type
5.3.5. By End User
5.3.6. By Region
6. North America Molecular Oncology Diagnostics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Technology
6.2.3. By Application
6.2.4. By Cancer Type
6.2.5. By End User
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Molecular Oncology Diagnostics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product Type
6.3.1.2.2. By Technology
6.3.1.2.3. By Application
6.3.1.2.4. By Cancer Type
6.3.1.2.5. By End User
6.3.2. Canada Molecular Oncology Diagnostics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product Type
6.3.2.2.2. By Technology
6.3.2.2.3. By Application
6.3.2.2.4. By Cancer Type
6.3.2.2.5. By End User
6.3.3. Mexico Molecular Oncology Diagnostics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product Type
6.3.3.2.2. By Technology
6.3.3.2.3. By Application
6.3.3.2.4. By Cancer Type
6.3.3.2.5. By End User
7. Europe Molecular Oncology Diagnostics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Technology
7.2.3. By Application
7.2.4. By Cancer Type
7.2.5. By End User
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Molecular Oncology Diagnostics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By Technology
7.3.1.2.3. By Application
7.3.1.2.4. By Cancer Type
7.3.1.2.5. By End User
7.3.2. France Molecular Oncology Diagnostics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By Technology
7.3.2.2.3. By Application
7.3.2.2.4. By Cancer Type
7.3.2.2.5. By End User
7.3.3. United Kingdom Molecular Oncology Diagnostics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By Technology
7.3.3.2.3. By Application
7.3.3.2.4. By Cancer Type
7.3.3.2.5. By End User
7.3.4. Italy Molecular Oncology Diagnostics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Type
7.3.4.2.2. By Technology
7.3.4.2.3. By Application
7.3.4.2.4. By Cancer Type
7.3.4.2.5. By End User
7.3.5. Spain Molecular Oncology Diagnostics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Type
7.3.5.2.2. By Technology
7.3.5.2.3. By Application
7.3.5.2.4. By Cancer Type
7.3.5.2.5. By End User
8. Asia-Pacific Molecular Oncology Diagnostics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Technology
8.2.3. By Application
8.2.4. By Cancer Type
8.2.5. By End User
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Molecular Oncology Diagnostics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By Technology
8.3.1.2.3. By Application
8.3.1.2.4. By Cancer Type
8.3.1.2.5. By End User
8.3.2. Japan Molecular Oncology Diagnostics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By Technology
8.3.2.2.3. By Application
8.3.2.2.4. By Cancer Type
8.3.2.2.5. By End User
8.3.3. India Molecular Oncology Diagnostics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.3.2.2. By Technology
8.3.3.2.3. By Application
8.3.3.2.4. By Cancer Type
8.3.3.2.5. By End User
8.3.4. South Korea Molecular Oncology Diagnostics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Type
8.3.4.2.2. By Technology
8.3.4.2.3. By Application
8.3.4.2.4. By Cancer Type
8.3.4.2.5. By End User
8.3.5. Australia Molecular Oncology Diagnostics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Type
8.3.5.2.2. By Technology
8.3.5.2.3. By Application
8.3.5.2.4. By Cancer Type
8.3.5.2.5. By End User
9. South America Molecular Oncology Diagnostics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Technology
9.2.3. By Application
9.2.4. By Cancer Type
9.2.5. By End User
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Molecular Oncology Diagnostics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By Technology
9.3.1.2.3. By Application
9.3.1.2.4. By Cancer Type
9.3.1.2.5. By End User
9.3.2. Argentina Molecular Oncology Diagnostics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By Technology
9.3.2.2.3. By Application
9.3.2.2.4. By Cancer Type
9.3.2.2.5. By End User
9.3.3. Colombia Molecular Oncology Diagnostics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
9.3.3.2.2. By Technology
9.3.3.2.3. By Application
9.3.3.2.4. By Cancer Type
9.3.3.2.5. By End User
10. Middle East and Africa Molecular Oncology Diagnostics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Technology
10.2.3. By Application
10.2.4. By Cancer Type
10.2.5. By End User
10.2.6. By Country
10.3. MEA: Country Analysis
10.3.1. UAE Molecular Oncology Diagnostics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.1.2.2. By Technology
10.3.1.2.3. By Application
10.3.1.2.4. By Cancer Type
10.3.1.2.5. By End User
10.3.2. Saudi Arabia Molecular Oncology Diagnostics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.2.2.2. By Technology
10.3.2.2.3. By Application
10.3.2.2.4. By Cancer Type
10.3.2.2.5. By End User
10.3.3. South Africa Molecular Oncology Diagnostics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Type
10.3.3.2.2. By Technology
10.3.3.2.3. By Application
10.3.3.2.4. By Cancer Type
10.3.3.2.5. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
13. Competitive Landscape
13.1. Business Overview
13.2. Product Offerings
13.3. Recent Developments
13.4. Financials (As Reported)
13.5. Key Personnel
13.5.1. Sysmex Corporation
13.5.2. F. Hoffmann-La Roche Ltd.
13.5.3. Myriad Genetics, Inc.
13.5.4. HTG Molecular Diagnostics, Inc.
13.5.5. Danaher Corporation.
13.5.6. QIAGEN N.V.
13.5.7. Bio-Rad Laboratories, Inc.
13.5.8. Agilent Technologies, Inc.
13.5.9. QIAGEN N.V.
13.5.10. Illumina, Inc.
14. Strategic Recommendations